GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » Total Assets

Hamilton Thorne (TSX:HTL) Total Assets : C$144.85 Mil (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne Total Assets?

Hamilton Thorne's Total Assets for the quarter that ended in Mar. 2024 was C$144.85 Mil.

Warning Sign:

If a company builds assets at 22% a year, faster than its revenue growth rate of 14.9% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Hamilton Thorne's average Total Assets Growth Rate was 38.10% per year. During the past 3 years, the average Total Assets Growth Rate was 29.50% per year. During the past 5 years, the average Total Assets Growth Rate was 22.00% per year. During the past 10 years, the average Total Assets Growth Rate was 55.60% per year.

During the past 13 years, Hamilton Thorne's highest 3-Year average Total Assets Growth Rate was 551.50%. The lowest was -1.50%. And the median was 31.00%.

Total Assets is connected with ROA %. Hamilton Thorne's annualized ROA % for the quarter that ended in Mar. 2024 was -3.48%. Total Assets is also linked to Revenue through Asset Turnover. Hamilton Thorne's Asset Turnover for the quarter that ended in Mar. 2024 was 0.18.


Hamilton Thorne Total Assets Historical Data

The historical data trend for Hamilton Thorne's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne Total Assets Chart

Hamilton Thorne Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.34 89.42 96.08 117.74 146.61

Hamilton Thorne Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 119.30 121.20 123.45 146.61 144.85

Hamilton Thorne Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Hamilton Thorne's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=86.736+59.87
=146.61

Hamilton Thorne's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=85.86+58.991
=144.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamilton Thorne  (TSX:HTL) Total Assets Explanation

Total Assets is connected with ROA %.

Hamilton Thorne's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-5.068/( (146.606+144.851)/ 2 )
=-5.068/145.7285
=-3.48 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Hamilton Thorne's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=26.25/( (146.606+144.851)/ 2 )
=26.25/145.7285
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Hamilton Thorne Total Assets Related Terms

Thank you for viewing the detailed overview of Hamilton Thorne's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamilton Thorne (TSX:HTL) Business Description

Traded in Other Exchanges
Address
100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915
Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.
Executives
Robert J Potter Director

Hamilton Thorne (TSX:HTL) Headlines

No Headlines